NCT00502515View on ClinicalTrials.gov

Dose-effect of SSR180575 in Diabetic Neuropathy

PHASE2CompletedINTERVENTIONAL

Enrollment

309

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Diabetic Neuropathies

Interventions

DRUG

SSR180575

Oral, once daily dosing

DRUG

Placebo

Oral, once daily dosing

Trial Locations (1)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY